Shattuck Labs (STTK) Non-Current Assets (2019 - 2026)
Shattuck Labs' (STTK) quarterly Non-Current Assets came in at $8.4 million in Q1 2026, down 22.26% year-on-year from $10.8 million in Q1 2025, and down 2.14% on a QoQ basis from $8.6 million in Q4 2025.
Shattuck Labs (STTK) Non-Current Assets (2019 - 2026) Analysis & Trends
Shattuck Labs (STTK) has 8 years of Non-Current Assets data on file, last reported at $8.4 million in Q1 2026.
- On a quarterly basis, Non-Current Assets fell 22.26% year-over-year to $8.4 million in Q1 2026; TTM through Mar 2026 was $36.2 million, a 27.21% decrease from a year earlier, with the FY2025 full-year figure at $8.6 million, down 27.74% from the prior year.
- Non-Current Assets for Q1 2026 stood at $8.4 million, down from $8.6 million in the prior quarter.
- Over the last five years, Non-Current Assets for STTK reached as high as $21.9 million in Q2 2022 and fell as low as $8.4 million in Q1 2026.
- Historically, Non-Current Assets has averaged $14.9 million across 5 years, with a median of $15.3 million in 2024.
- Across the five-year window, Non-Current Assets soared 177.44% in 2022 and tumbled 31.67% in 2025, its largest moves.
- Year by year, Non-Current Assets stood at $20.7 million in 2022, then slipped by 21.2% to $16.3 million in 2023, then fell by 27.59% to $11.8 million in 2024, then decreased by 27.74% to $8.6 million in 2025, then decreased by 2.14% to $8.4 million in 2026.
- Per Business Quant data, the three most recent Non-Current Assets figures were $8.4 million in Q1 2026, $8.6 million in Q4 2025, and $9.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 21.65 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 5.83 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1.95 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 3.95 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 14.75 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.66 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 289.41 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.96 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 285.82 Mn |
| 10 | Shattuck Labs | 795.74 Mn | 795.74 Mn | - | 8.37 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.37 Mn |
| Dec 31, 2025 | 8.55 Mn |
| Sep 30, 2025 | 9.61 Mn |
| Jun 30, 2025 | 9.70 Mn |
| Mar 31, 2025 | 10.76 Mn |
| Dec 31, 2024 | 11.83 Mn |
| Sep 30, 2024 | 12.98 Mn |
| Jun 30, 2024 | 14.19 Mn |
| Mar 31, 2024 | 15.26 Mn |
| Dec 31, 2023 | 16.34 Mn |
| Sep 30, 2023 | 17.47 Mn |
| Jun 30, 2023 | 18.82 Mn |
| Mar 31, 2023 | 19.84 Mn |
| Dec 31, 2022 | 20.74 Mn |
| Sep 30, 2022 | 21.43 Mn |
| Jun 30, 2022 | 21.92 Mn |
| Mar 31, 2022 | 15.50 Mn |
| Dec 31, 2021 | 10.32 Mn |
| Sep 30, 2021 | 8.92 Mn |
| Jun 30, 2021 | 7.90 Mn |